The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:
Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.
- Data on the outcome of ongoing fertility care.
- Data on gametes/embryos, fresh or frozen, from patients exposed to SARS-CoV-2.
- Other information related to fertility outcomes.
The Ferring COVID-19 Investigational Grants are awarded a single time and are not renewable.